Purchase Order 140G0123P0069
- Not listed
- This is a firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc., a manufacturer of genomic sequencing instruments and solutions. The contract is for $71,643.00 to provide service maintenance for an Illumina MiSeq sequencer. The award has no set-aside designation and the period of performance runs through June 10, 2024. Illumina has a history of providing sequencing systems and related services to various government agencies,...
- This is a firm fixed-price delivery order awarded by the Animal and Plant Health Inspection Service, a civilian agency within the U.S. Department of Agriculture, to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents. The $14,562.62 award is for the renewal of a service contract to provide maintenance and support for Illumina's MiSeq sequencing equipment. The order has a period of performance through July 29, 2024 and does not include any set-aside...
- Illumina, Inc. was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $4,050 for maintenance and recertification services on a MiSeq System sequencing instrument. The contract, issued on March 27, 2017, with completion targeted for April 30, 2017, encompasses preventive maintenance labor, travel expenses, replacement parts included in the preventive maintenance kit, and system recertification following equipment relocation. The work is to be performed in Albany,...
- Illumina, Inc. has been awarded a purchase order valued at $89,930.78 for annual MiSeq support and maintenance services, with an ultimate completion date of October 27, 2029. The contract, awarded on August 12, 2024, by the Office of Acquisitions and Grants, utilizes firm fixed pricing with no set-aside designation. Performance will take place in Honolulu, Hawaii. The MiSeq is a mid-throughput genomic sequencing instrument widely used in research and diagnostic applications, and this contract...
- Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a delivery order valued at $15,349.28 for MiSeq Silver Support Plan maintenance services on a MiSeq sequencing instrument (serial number M01098) located in Ames, Iowa. The contract, awarded on December 16, 2025, carries a firm fixed price structure with an ultimate completion date of December 15, 2026. This delivery order does not utilize a set-aside designation,...
- The U.S. government agency awarded a $12,888.96 firm fixed-price purchase order contract to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The "MISEQ SILVER SUPPORT PLAN" contract, which does not have a set-aside designation, is for the provision of maintenance and support services for the agency's MiSeq sequencing platform. Illumina, Inc., the prime contractor, is a for-profit manufacturer of goods headquartered in San...
- This firm fixed-price delivery order was awarded to Illumina, Inc. by the Plains Area division of a civilian federal agency. The $14,562.62 contract provides a support plan for an Illumina MiSeq sequencing instrument, with a period of performance through September 15, 2024. This award does not utilize a set-aside. Illumina is a leading provider of sequencing and genomic analysis instrumentation and reagents, having received numerous past prime contract and subcontract awards from agencies like...
- Illumina, Inc. was awarded a firm fixed-price purchase order valued at $15,470.75 for a DNA Sequencer MiSeq Comprehensive Plan annual service contract with quarterly payments. The contract, which was awarded on May 6, 2016, with an ultimate completion date of May 9, 2017, covers product care and maintenance services for the MiSeq sequencing instrument. The place of performance is located in San Diego, California, and the contract was funded by a civilian federal agency within the Midwest Area....
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for $12,450.00 to provide preventative maintenance services for Illumina's MISEQ sequencing system. The contract has an ultimate completion date of June 30, 2018 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
- This is a firm fixed price delivery order contract awarded to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents, to provide a support plan for an Illumina MiSeq sequencing instrument. The $15,145.13 contract was awarded by the Plains Area division of an unnamed civilian federal agency. Illumina has previously provided a range of sequencing systems and related goods and services to support research and diagnostics at agencies like the NIH, CDC, USDA, and...
Illumina, Inc. was awarded a $78,115 firm fixed-price purchase order by the Office of Acquisitions and Grants on January 12, 2023, for maintenance support services on a MiSeq M06789 sequencing instrument. The contract establishes a base period plus four option years, with an ultimate completion date of February 22, 2028. The award includes an estimated annual uplift of 4% applied at each option year exercise, with pricing adjusted downward if manufacturer list prices decrease below quoted amounts. This modification exercises Option Year 2 of the contract. The work will be performed in Kearneysville, West Virginia. No small business set-aside was utilized for this procurement. As a specialized biotechnology manufacturer, Illumina provides comprehensive genomic sequencing and analysis solutions across federal agencies. The company holds a substantial $45 million indefinite delivery vehicle with the U.S. Department of Agriculture and maintains extensive contracting relationships with the National Institutes of Health, Department of Veterans Affairs, Defense Health Agency, National Cancer Institute, and Food and Drug Administration. Maintenance contracts such as this one support federal research and diagnostic initiatives by ensuring continued operational capability of critical laboratory equipment used in genomic research, infectious disease analysis, and related scientific endeavors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $16.2k | 2/4/26 | |
| P00002 | Exercise an Option | $15.6k | 1/29/25 | |
| P00001 | Exercise an Option | $15.0k | 2/22/24 | |
| Not listed | Not listed | $14.4k | 1/19/23 |